FDA Greenlights CRISPR Therapy for Sickle Cell Anemia
Vertex and CRISPR Therapeutics secure full approval for the first gene-editing therapy to enter mainstream clinical use.
The U.S. Food and Drug Administration has approved Exa-Cel, a CRISPR-Cas9-b...
